| http://www.w3.org/ns/prov#value | - Forty-three of these pending ANDAs are potential first-to-file opportunities, representing $26.6 billion in annual brand sales, for the 12 months ending June 30, 2011, according to IMS Health.This press release includes statements that constitute forward-looking statements, including with regard to product approvals and regulatory matters.
|
